AIM-HI Accelerator Fund logo

AIM-HI Accelerator Fund

North America, Maryland, United States, Rockville

Description

AIM-HI Accelerator Fund is a non-profit organization that supports startup oncology companies commercializing innovative lab breakthroughs.

Investor Profile

AIM-HI Accelerator Fund has made 2 investments, with 1 in the past 12 months and 0% as lead.

Stage Focus

  • Seed (50%)
  • Series A (50%)

Country Focus

  • Singapore (50%)
  • China (50%)

Industry Focus

  • Biotechnology
  • Life Science
  • Medical
  • Health Care
  • Oncology
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does AIM-HI Accelerator Fund frequently co-invest with?

Prox Ventures
Asia, Shanghai, China, Shanghai
Co-Investments: 1
Takeda Ventures
North America, California, United States, San Diego
Co-Investments: 1
Gaorong Capital
Asia, Beijing, China, Wangjing
Co-Investments: 1
BioVenture
Asia, Jiangsu, China, Suzhou
Co-Investments: 1
FC Capital
Asia, Shanghai, China, Shanghai
Co-Investments: 1

What are some of recent deals done by AIM-HI Accelerator Fund?

Degron Therapeutics

Shanghai, Shanghai, China

Degron Therapeutics is a platform company in discovery of molecular glue degraders for cancer treatment.

BiotechnologyHealth CareOncology
Series AJan 22, 2025
DotBio

Singapore, Central Region, Singapore

DotBio develops multi-functional antibodies based on its proprietary DotBody technology as the next generation of cancer therapies.

BiotechnologyLife ScienceMedical
SeedAug 7, 2023
Amount Raised: $5,600,000